Activist investor Nelson Peltz's Trian Fund Management LP, among the biggest shareholders in DuPont , has called on the chemical conglomerate to separate its high-growth businesses from those that generate strong cash flows. Trian Fund, which holds a $1.6 billion stake in DuPont, wants the company to split into two - one holding its fast-growing agriculture, nutrition and health and industrial biosciences divisions.